At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Apr 24, 2026 at 16:32 ET
Three insiders at United Therapeutics (UTHR), including the CEO and CFO, sold a total of ~$3.48M in stock over a five-day period. All sales were preceded by derivative exercises (stock options) and represent routine cash-out transactions. At $24.9B market cap, the total sales are negligible (0.014% of market cap), carrying no material signal.
- CEO Martine Rothblatt sold 2,306 shares for ~$1.1M across multiple days.
- CFO James Edgemond sold 1,716 shares for ~$971K.
- Director Christopher Patusky sold 2,910 shares for ~$1.66M.
- All sales were accompanied by stock option exercises at $0 or near-market prices.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access